Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.590
+0.150 (4.36%)
At close: May 29, 2026, 4:00 PM EDT
3.520
-0.070 (-1.95%)
After-hours: May 29, 2026, 7:59 PM EDT
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $1.91 billion as of May 29, 2026. Its market cap has increased by 8.65% in one year.
Market Cap
1.91B
Enterprise Value
1.32B
1-Year Change
8.65%
Ranking
Category
Stock Price
$3.59
Market Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $5.08B to $1.91B, a decrease of -62.46%. That is a compound annual growth rate of -17.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 1.90B | -10.74% |
| Dec 31, 2025 | 2.13B | -20.16% |
| Dec 31, 2024 | 2.67B | 24.83% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -42.96% |
| Apr 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syndax Pharmaceuticals | 1.74B |
| Agios Pharmaceuticals | 1.70B |
| Biohaven | 1.70B |
| Capricor Therapeutics | 1.69B |
| AnaptysBio | 1.68B |
| Generate Biomedicines | 1.68B |
| Palvella Therapeutics | 1.67B |
| AbCellera Biologics | 1.66B |